Nota Bene Cancer
Nota Bene Cancer est un bulletin hebdomadaire de veille bibliographique. En libre accès, Nota Bene Cancer permet à ses abonnés de gagner du temps pour se tenir informé de l’actualité scientifique et médicale dans les divers domaines de la recherche sur les cancers.
Pour retrouver les publications signalées par Nota Bene Cancer (archives indexées à partir du n°127 du 1" mars 2012) :
Sommaire du n° 548 du 5 janvier 2023
Lutte contre les cancers
Qualité de vie, soins de support (2)
A partir d'une revue systématique de la littérature publiée jusqu'en août 2021 (9 études incluant 6 023 aidants), cette étude analyse les besoins en soins de support et la qualité de vie des proches aidants de patients atteints d'un cancer du pancréas
Systematic review of caregiver burden, unmet needs and quality-of-life among informal caregivers of patients with pancreatic cancer
A partir d'une revue systématique de la littérature publiée jusqu'en août 2021 (9 études incluant 6 023 aidants), cette étude analyse les besoins en soins de support et la qualité de vie des proches aidants de patients atteints d'un cancer du pancréas
Systematic review of caregiver burden, unmet needs and quality-of-life among informal caregivers of patients with pancreatic cancer
Chong, Eric ; Crowe, Lisa ; Mentor, Keno ; Pandanaboyana, Sanjay ; Sharp, Linda
Purpose: Informal caregivers play an important supportive care role for patients with cancer. This may be especially true for pancreatic cancer which is often diagnosed late, has a poor prognosis and is associated with a significant symptom burden. We systematically reviewed the evidence on caregiver burden, unmet needs and quality-of-life of informal caregivers to patients with pancreatic cancer. Method: PubMed, Medline, CINAHL and Embase databases were systematically searched on 31 August [...]
Menée aux Pays-Bas à partir de données portant sur 1 525 patients atteints d'un cancer rare et sur 1 047 patients atteints d'un cancer colorectal, cette étude compare la qualité de vie de ces deux populations
Quality of life of patients with rare cancer: a comparison with patients with colorectal cancer and the association with disease trajectory-related...
Menée aux Pays-Bas à partir de données portant sur 1 525 patients atteints d'un cancer rare et sur 1 047 patients atteints d'un cancer colorectal, cette étude compare la qualité de vie de ces deux populations
Quality of life of patients with rare cancer: a comparison with patients with colorectal cancer and the association with disease trajectory-related factors
Driehuis, Esmee ; de Heus, Eline ; Schrieks, Marga ; Engelen, Vivian ; Buffart, Tineke E. ; Vink, Geraldine R. ; Duijts, Saskia F. A.
Purpose: Differences in quality of life (QoL) between patients with rare and common cancer might be explained by the specific challenges patients with rare cancer face during their disease trajectory, but research is scarce. This study aimed to (1) assess the difference in QoL between patients with rare and common cancer (i.e. colorectal cancer (CRC)) and (2) examine the association between disease trajectory-related factors and QoL in patients with rare cancer. Methods: Cross-sectional data [...]
Observation (9)
Menée à partir des données 1992-2019 des registres américains des cancers, cette étude analyse l'évolution de l'incidence du cancer gastrique, de la mortalité et de la survie associées
Incidence and mortality trends in gastric cancer in the United States, 1992–2019
Menée à partir des données 1992-2019 des registres américains des cancers, cette étude analyse l'évolution de l'incidence du cancer gastrique, de la mortalité et de la survie associées
Incidence and mortality trends in gastric cancer in the United States, 1992–2019
Chen, Mengding ; Chen, Ke ; Hou, Huanan ; Li, Wanjing ; Wang, Xiaoshan ; Dao, Qianze ; Wang, Zhengguang
Abstract This study aimed to estimate the epidemiological trends of gastric cancer in the United States from 1992 to 2019. This population-based study used the US Surveillance, Epidemiology, and End Results–12 database as a fundamental cohort to analyze gastric cancer incidence, incidence-based mortality (IBM), overall survival (OS) and cancer-specific survival (CSS) probabilities from 1992 to 2019. The Global Burden of Disease study (1990–2018) was used as a likely validation cohort. [...]
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Decrease of cancer diagnosis during COVID-19 pandemic: a systematic review and meta-analysis
Angelini, Marco ; Teglia, Federica ; Astolfi, Laura ; Casolari, Giulia ; Boffetta, Paolo
Many health services, including cancer care, have been affected by the COVID-19 epidemic. This study aimed at providing a systematic review of the impact of the epidemic on cancer diagnostic tests and diagnosis worldwide. In our systematic review and meta-analysis, databases such as Pubmed, Proquest and Scopus were searched comprehensively for articles published between January 1st, 2020 and December 12th, 2021. Observational studies and articles that reported data from single clinics and [...]
COVID-19 Impact on Chronic Myeloid Leukemia Patients
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
COVID-19 Impact on Chronic Myeloid Leukemia Patients
Arbore, Dana Raluca ; Galdean, Simona Maria ; Dima, Delia ; Rus, Ioana ; Kegyes, David ; Ababei, Raluca Geanina ; Dragancea, Daniela ; Tomai, Radu Andrei ; Trifa, Adrian Pavel ; Tomuleasa, Ciprian
Background: Chronic myeloid leukemia (CML) is a blood dyscrasia that accounts for about 20% of all leukemia cases. Tyrosine kinase inhibitors (TKIs) are used as first line treatment of CML. The 2019 SARS-CoV-2 outbreak raised new concerns for CML patients, such as whether CML increases the risk of contracting COVID-19, whether TKIs increase that risk, whether these drugs are safe to use during the infection, and whether any other hematologic parameters influence infection outcomes. (2) Methods: [...]
Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis
Chuleerarux, Nipat ; Manothummetha, Kasama ; Moonla, Chatphatai ; Sanguankeo, Anawin ; Kates, Olivia S. ; Hirankarn, Nattiya ; Phongkhun, Kasidis ; Thanakitcharu, Jaedvara ; Leksuwankun, Surachai ; Meejun, Tanaporn ; Thongkam, Achitpol ; Mongkolkaew, Thanuthong ; Dioverti, M. Veronica ; Torvorapanit, Pattama ; Langsiri, Nattapong ; Worasilchai, Navaporn ; Plongla, Rongpong ; Chindamporn, Ariya ; Gopinath, Shilpa ; Nissaisorakarn, Pitchaphon ; Thaniyavarn, Tany ; Nematollahi, Saman ; Permpalung, Nitipong
Patients with multiple myeloma (MM) have a diminished immune response to coronavirus disease 2019 (COVID-19) vaccines. Risk factors for an impaired immune response are yet to be determined. We aimed to summarize the COVID-19 vaccine immunogenicity and to identify factors that influence the humoral immune response in patients with MM. Two reviewers independently conducted a literature search in MEDLINE, Embase, ISI Web of Science, Cochrane library, and Clinicaltrials.gov from existence until 24 [...]
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
Denkinger, Claudia M. ; Janssen, Maike ; Schäkel, Ulrike ; Gall, Julia ; Leo, Albrecht ; Stelmach, Patrick ; Weber, Stefan F. ; Krisam, Johannes ; Baumann, Lukas ; Stermann, Jacek ; Merle, Uta ; Weigand, Markus A. ; Nusshag, Christian ; Bullinger, Lars ; Schrezenmeier, Jens-Florian ; Bornhäuser, Martin ; Alakel, Nael ; Witzke, Oliver ; Wolf, Timo ; Vehreschild, Maria J. G. T. ; Schmiedel, Stefan ; Addo, Marylyn M. ; Herth, Felix ; Kreuter, Michael ; Tepasse, Phil-Robin ; Hertenstein, Bernd ; Hänel, Mathias ; Morgner, Anke ; Kiehl, Michael ; Hopfer, Olaf ; Wattad, Mohammad-Amen ; Schimanski, Carl C. ; Celik, Cihan ; Pohle, Thorsten ; Ruhe, Matthias ; Kern, Winfried V. ; Schmitt, Anita ; Lorenz, Hanns-Martin ; Souto-Carneiro, Margarida ; Gaeddert, Mary ; Halama, Niels ; Meuer, Stefan ; Kräusslich, Hans-Georg ; Müller, Barbara ; Schnitzler, Paul ; Parthé, Sylvia ; Bartenschlager, Ralf ; Gronkowski, Martina ; Klemmer, Jennifer ; Schmitt, Michael ; Dreger, Peter ; Kriegsmann, Katharina ; Schlenk, Richard F. ; Müller-Tidow, Carsten
Patients with cancer are at high risk of severe coronavirus disease 2019 (COVID-19), with high morbidity and mortality. Furthermore, impaired humoral response renders severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines less effective and treatment options are scarce. Randomized trials using convalescent plasma are missing for high-risk patients. Here, we performed a randomized, open-label, multicenter trial [...]
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer
Gong, Inna Y. ; Vijenthira, Abi ; Powis, Melanie ; Calzavara, Andrew ; Patrikar, Aditi ; Sutradhar, Rinku ; Hicks, Lisa K. ; Wilton, Drew ; Singh, Simron ; Krzyzanowska, Monika K. ; Cheung, Matthew C.
Importance : Patients with cancer are known to have increased risk of COVID-19 complications, including death. Objective : To determine the association of COVID-19 vaccination with breakthrough infections and complications in patients with cancer compared to noncancer controls. Design, Setting, and Participants : Retrospective population-based cohort study using linked administrative databases in Ontario, Canada, in residents 18 years and older who received COVID-19 vaccination. Three matched [...]
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-se...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional Evaluation
Lee, Lennard Y. W. ; Tilby, Michael ; Starkey, Thomas ; Ionescu, Maria C. ; Burnett, Alex ; Hattersley, Rosie ; Khan, Sam ; Little, Martin ; Liu, Justin K. H. ; Platt, James R. ; Tripathy, Arvind ; Watts, Isabella ; Williams, Sophie Therese ; Appanna, Nathan ; Al-Hajji, Youssra ; Barnard, Matthew ; Benny, Liza ; Buckley, Andrew ; Cattell, Emma ; Cheng, Vinton ; Clark, James ; Eastlake, Leonie ; Gerrand, Kate ; Ghafoor, Qamar ; Grumett, Simon ; Harper-Wynne, Catherine ; Kahn, Rachel ; Lee, Alvin J. X. ; Lydon, Anna ; McKenzie, Hayley ; Panneerselvam, Hari ; Pascoe, Jennifer ; Patel, Grisma ; Patel, Vijay ; Potter, Vanessa ; Randle, Amelia ; Rigg, Anne S. ; Robinson, Tim ; Roylance, Rebecca ; Roques, Tom ; Rozmanowski, Stefan ; Roux, Rene L. ; Shah, Ketan ; Sintler, Martin ; Taylor, Harriet ; Tillett, Tania ; Tuthill, Mark ; Williams, Sarah ; Beggs, Andrew ; Iveson, Tim ; Lee, Siow Ming ; Middleton, Gary ; Middleton, Mark ; Protheroe, Andrew S. ; Fittall, Matthew W. ; Fowler, Tom ; Johnson, Peter ; UK COVID Cancer Programme
Accurate identification of patient groups with the lowest level of protection following COVID-19 vaccination is important to better target resources and interventions for the most vulnerable populations. It is not known whether SARS-CoV-2 antibody testing has clinical utility for high-risk groups, such as people with cancer.To evaluate whether spike protein antibody vaccine response (COV-S) following COVID-19 vaccination is associated with the risk of SARS-CoV-2 breakthrough infection or [...]
Impact of the COVID-19 Pandemic on Liver Cancer Staging at a Multidisciplinary Liver Cancer Clinic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Impact of the COVID-19 Pandemic on Liver Cancer Staging at a Multidisciplinary Liver Cancer Clinic
Li, Daniel ; Jia, Angela Y. ; Zorzi, Jane ; Griffith, Paige ; Kim, Amy K. ; Dao, Doan ; Anders, Robert A. ; Georgiades, Christos ; Liddell, Robert P. ; Hong, Kelvin ; Azad, Nilofer S. ; Ho, Won Jin ; Baretti, Marina ; Christenson, Eric ; Baghdadi, Azarakhsh ; Kamel, Ihab R. ; Meyer, Jeffrey ; Ghabi, Elie ; Burkhart, Richard A. ; Lafaro, Kelly ; He, Jin ; Shubert, Chris ; Yarchoan, Mark
Objectives: To compare liver cancer resectability rates before and during the COVID-19 pandemic. Background: Liver cancers usually present with nonspecific symptoms or are diagnosed through screening programs for at-risk patients, and early detection can improve patient outcomes. In 2020, the COVID-19 pandemic upended medical care across all specialties, but whether the pandemic was associated with delays in liver cancer diagnosis is not known. Methods: We performed a retrospective review of [...]
Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer Database
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer Database
Nogueira, Leticia M. ; Palis, Bryan ; Boffa, Daniel ; Lum, Sharon ; Yabroff, K. Robin ; Nelson, Heidi
Purpose: This study evaluated the reliability of cancer cases reported to the National Cancer Database (NCDB) during 2020, the first year of the COVID-19 pandemic. Methods: Total number of cancer cases reported to the NCDB between January 2018 and December 2020 were calculated for all cancers and 21 selected cancer sites. The additive outlier method was used to identify structural breaks in trends compared with previous years. The difference between expected (estimated using the vector [...]
Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
Piening,Alexander ; Ebert,Emily ; Khojandi,Niloufar ; Alspach,Elise ; Teague,Ryan M.
Vaccination against SARS-CoV-2 has been successful in protecting patients with cancer from severe infections, but how immune responses against COVID-19 vaccination interact with those elicited during cancer immunotherapy has not been fully described. Immune checkpoint blockade (ICB) disrupts inhibitory pathways in immune cells to improve function and induce tumor immunity but can often cause serious immune related adverse events (IRAEs). Because COVID-19 vaccination and ICB both boost immune [...]
Effectiveness of Convalescent Plasma Therapy in COVID-19 Patients with Hematological Malignancies: A Systematic Review
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Effectiveness of Convalescent Plasma Therapy in COVID-19 Patients with Hematological Malignancies: A Systematic Review
Shibeeb, Sapha ; Ajaj, Ilham ; Al-Jighefee, Hadeel ; Abdallah, Atiyeh M.
Background: Immunocompromised patients, including those with hematological malignancies, are at a high risk of developing severe coronavirus disease 2019 (COVID-19) complications. Currently, there is a limited number of systematic reviews into the efficacy of convalescent plasma therapy (CPT) use in the treatment of COVID-19 patients with hematological malignancies. Therefore, the aim of this review was to systematically appraise the current evidence for the clinical benefits of this therapy in [...]
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia
Tiacci, Enrico ; Mancini, Alessandro ; Marchetti, Monia ; D'Elia, Gianna Maria ; Candoni, Anna ; Morotti, Alessandro ; Romano, Alessandra ; Gozzetti, Alessandro ; Broccoli, Alessandro ; De Carolis, Luca ; Bruna, Riccardo ; Tisi, Maria Chiara ; Selleri, Carmine ; Capponi, Monia ; Vallisa, Daniele ; Cattaneo, Chiara ; Della Porta, Matteo Giovanni ; Busca, Alessandro ; Falini, Brunangelo ; Massaia, Massimo ; Bertù, Lorenza ; Pulsoni, Alessandro ; Rivela, Paolo ; Corradini, Paolo ; Passamonti, Francesco
Little is known of the course of COVID-19 and the antibody response to infection or vaccination in patients with hairy-cell leukaemia (HCL). Among a total of 58 HCL cases we studied in these regards, 37 unvaccinated patients, mostly enjoying a relatively long period free from anti-leukaemic treatment, developed COVID-19 between March 2020 and December 2021 with a usually favourable outcome (fatality rate: 5/37, 14%); however, active leukaemia, older age and more comorbidities were associated [...]
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients:...
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis
Uaprasert, Noppacharn ; Pitakkitnukun, Palada ; Tangcheewinsirikul, Nuanrat ; Chiasakul, Thita ; Rojnuckarin, Ponlapat
Patients with hematologic malignancies (HM) have demonstrated impaired immune responses following SARS-CoV-2 vaccination. Factors associated with poor immunogenicity remain largely undetermined. A literature search was conducted using PubMed, EMBASE, Cochrane, and medRxiv databases to identify studies that reported humoral or cellular immune responses (CIR) following complete SARS-CoV-2 vaccination. The primary aim was to estimate the seroconversion rate (SR) following complete SARS-CoV-2 [...]
Menée dans 7 pays à haut revenu (Australie, Canada, Danemark, Irlande, Nouvelle-Zélande, Norvège et Royaume-Uni) à partir de données 1995-2014 portant sur des patientes atteintes d'un cancer épithélial de l'ovaire, cette étude analyse l'évolution de l'incidence de la maladie et de la survie, par sous-type histologique et par catégorie d'âge (15-64 ans et 65-99 ans)
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): a SurvMark-2 study
Menée dans 7 pays à haut revenu (Australie, Canada, Danemark, Irlande, Nouvelle-Zélande, Norvège et Royaume-Uni) à partir de données 1995-2014 portant sur des patientes atteintes d'un cancer épithélial de l'ovaire, cette étude analyse l'évolution de l'incidence de la maladie et de la survie, par sous-type histologique et par catégorie d'âge (15-64 ans et 65-99 ans)
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): a SurvMark-2 study
Cabasag, Citadel J. ; Arnold, Melina ; Rutherford, Mark ; Ferlay, Jacques ; Bardot, Aude ; Morgan, Eileen ; Butler, John ; O'Connell, Dianne L ; Nelson, Gregg ; Høgdall, Claus ; Schnack, Tine ; Gavin, Anna ; Elwood, Mark ; Hanna, Louise ; Gourley, Charlie ; De, Prithwish ; Saint-Jacques, Nathalie ; Mørch, Lina Steinrud ; Woods, Ryan R ; Altman, Alon D. ; Sykes, Peter ; Cohen, Paul A. ; McNally, Orla ; Møller, Bjørn ; Walsh, Paul ; Morrison, David S ; Bray, Freddie ; Soerjomataram, Isabelle
The aim of the study is to provide a comprehensive assessment of incidence and survival trends of epithelial ovarian cancer (EOC) by histological subtype across seven high income countries (Australia, Canada, Denmark, Ireland, New Zealand, Norway, and the United Kingdom). Data on invasive EOC diagnosed in women aged 15-99 years during 1995-2014 were obtained from 20 cancer registries. Age standardized incidence rates and average annual percentage change were calculated by subtype for all ages [...]
Menée aux Etats-Unis à partir de données portant sur 318 548 patients atteints d'un adénocarcinome du rectum diagnostiqué entre 2004 et 2019, cette étude rétrospective analyse l'évolution des traitements et de la survie
Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019: A National Cancer Database Analysis
Menée aux Etats-Unis à partir de données portant sur 318 548 patients atteints d'un adénocarcinome du rectum diagnostiqué entre 2004 et 2019, cette étude rétrospective analyse l'évolution des traitements et de la survie
Trends in the Characteristics, Treatment, and Outcomes of Rectal Adenocarcinoma in the US From 2004 to 2019: A National Cancer Database Analysis
Emile, Sameh H. ; Horesh, Nir ; Freund, Michael R. ; Garoufalia, Zoe ; Gefen, Rachel ; Silva-Alvarenga, Emanuela ; Maron, David J. ; DaSilva, Giovanna ; Wexner, Steven D.
Importance : Rectal cancer management has significantly evolved over the last 2 decades. Objective : This study aimed to evaluate trends in the characteristics, treatment, and outcomes of rectal adenocarcinoma across 16 years. Design, Setting, and Participants : This retrospective, observational case series study used data from the National Cancer Database (NCDB) to evaluate patients diagnosed with rectal adenocarcinoma from 2004 through 2019. Data analysis was performed from March to May 2022. [...]
Menée en Angleterre à partir des données 2013-2017 du registre des cancers portant sur 19 717 patients atteints d'un sarcome des tissus mous, cette étude analyse l'incidence de la maladie par sous-type, la survie globale et la survie nette à 5 ans
Incidence and survival of soft tissue sarcoma in England between 2013-2017, an analysis from the National Cancer Registration and Analysis Service
Menée en Angleterre à partir des données 2013-2017 du registre des cancers portant sur 19 717 patients atteints d'un sarcome des tissus mous, cette étude analyse l'incidence de la maladie par sous-type, la survie globale et la survie nette à 5 ans
Incidence and survival of soft tissue sarcoma in England between 2013-2017, an analysis from the National Cancer Registration and Analysis Service
Bacon, Andrew ; Wong, Kwok ; Fernando, Malee S. ; Rous, Brian ; Hill, Roger J.W. ; Collins, Shane D. ; BroggioJ, John ; Strauss, Sandra J.
There is a paucity of population-based data detailing the incidence and survival of patients with soft tissue sarcoma (STS), in part due to the heterogeneity of disease and changes to classification. Here, the incidence and survival of all STS subtypes registered in England between 2013 and 2017 were analysed using cancer registry data held by the National Cancer Registration and Analysis Service. Age standardised incidence rates were calculated per 1,000,000 using the 2013 European Standard [...]
Menée à partir des données des registres américains des cancers portant sur 39 029 patientes ayant survécu à un cancer du sein et ayant développé un second cancer entre 2000 et 2014 (durée de suivi : 17 ans), cette étude analyse les disparités ethniques dans la mortalité (15 117 décès)
Racial and ethnic disparities in mortality among breast cancer survivors after a second malignancy
Menée à partir des données des registres américains des cancers portant sur 39 029 patientes ayant survécu à un cancer du sein et ayant développé un second cancer entre 2000 et 2014 (durée de suivi : 17 ans), cette étude analyse les disparités ethniques dans la mortalité (15 117 décès)
Racial and ethnic disparities in mortality among breast cancer survivors after a second malignancy
Deng, Zhengyi ; Jones, Miranda R ; Wang, Mei-Cheng ; Wolff, Antonio C ; Visvanathan, Kala
Background: Racial and ethnic differences in survival after a first cancer are well established but have not been examined after a SPC despite the increasing incidence among survivors. Methods: We examined 39,029 female breast cancer survivors who developed a SPC between 2000-2014 in the Surveillance, Epidemiology, and End Results (SEER) 18 database. Multivariable Cox proportional hazard regression for competing risks data was used to estimate hazard ratio (HR) and 95% confidence interval (CI) [...]
Menée à partir des données 1988-2017 des registres américains des cancers portant sur 8 481 hommes atteints d'un cancer du sein, cette étude analyse l'évolution de la survie spécifique et de la survie globale
Survival in male breast cancer over the past three decades
Menée à partir des données 1988-2017 des registres américains des cancers portant sur 8 481 hommes atteints d'un cancer du sein, cette étude analyse l'évolution de la survie spécifique et de la survie globale
Survival in male breast cancer over the past three decades
Leone, José P ; Freedman, Rachel A ; Leone, Julieta ; Tolaney, Sara M ; Vallejo, Carlos T ; Leone, Bernardo A ; Winer, Eric P ; Lin, Nancy U ; Hassett, Michael J
Background: Breast cancer mortality in women has declined significantly over the past several years. In men, it is unclear whether survival has changed over time. We evaluated changes in breast cancer-specific survival (BCSS) and overall survival (OS) in male breast cancer (MaBC) over the past 3 decades. Methods: We evaluated men diagnosed with breast cancer between 1988 and 2017, reported in the Surveillance, Epidemiology, and End Results registry. Patients were categorized into 3 groups by [...]
Menée à partir de données portant sur 402 patientes atteintes d'un cancer du sein et incluses dans un essai de phase III, cette étude analyse l'effet de la durée des nausées et vomissements lors du premier cycle de chimiothérapie sur le risque de récidive de ces nausées et vomissements pendant les cycles ultérieurs de chimiothérapie
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles
Menée à partir de données portant sur 402 patientes atteintes d'un cancer du sein et incluses dans un essai de phase III, cette étude analyse l'effet de la durée des nausées et vomissements lors du premier cycle de chimiothérapie sur le risque de récidive de ces nausées et vomissements pendant les cycles ultérieurs de chimiothérapie
Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles
Navari, Rudolph ; Binder, Gary ; Molasiotis, Alex ; Herrstedt, Jørn ; Roeland, Eric J ; Ruddy, Kathryn J ; LeBlanc, Thomas W ; Kloth, Dwight D ; Klute, Kelsey A ; Papademetriou, Eros ; Schmerold, Luke ; Schwartzberg, Lee
Background: The relationship between CINV duration and recurrence in subsequent cycles is largely unstudied. Our objective was to determine if patients experiencing CINV in their first cycle of chemotherapy (C1) would face increased risk of CINV in later cycles and whether the duration of the CINV would predict increased risk of recurrence. Patients and Methods: Using data from a previously reported phase III trial, we assessed patients’ recurrence of breakthrough CINV after antiemetic [...]
Menée aux Etats-Unis à partir de données portant sur 5 051 témoins et sur 1 397 patients ayant survécu 5 ans ou plus à un neuroblastome diagnostiqué avant l'âge de 1 an sur la période 1970-1999, cette étude analyse le risque de second cancer, les morbidités et la mortalité à long terme (plus de 5 ans après le diagnostic)
Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study
Menée aux Etats-Unis à partir de données portant sur 5 051 témoins et sur 1 397 patients ayant survécu 5 ans ou plus à un neuroblastome diagnostiqué avant l'âge de 1 an sur la période 1970-1999, cette étude analyse le risque de second cancer, les morbidités et la mortalité à long terme (plus de 5 ans après le diagnostic)
Long-Term Morbidity and Mortality Among Survivors of Neuroblastoma Diagnosed During Infancy: A Report From the Childhood Cancer Survivor Study
Danielle Novetsky Friedman ; Pamela J. Goodman ; Wendy M. Leisenring ; Lisa R. Diller ; Susan L. Cohn ; Rebecca M. Howell ; Susan A. Smith ; Emily S. Tonorezos ; Suzanne L. Wolden ; Joseph P. Neglia ; Kirsten K. Ness ; Todd M. Gibson ; Paul C. Nathan ; Brent R. Weil ; Leslie L. Robison ; Kevin C. Oeffinger ; Gregory T. Armstrong ; Charles A. Sklar ; Tara O. Henderson
PURPOSE: To describe the risk of late mortality, subsequent malignant neoplasms (SMNs), and chronic health conditions (CHCs) in survivors of neuroblastoma diagnosed in infancy by treatment era and exposures. METHODS: Among 5-year survivors of neuroblastoma in the Childhood Cancer Survivor Study diagnosed age < 1 year between 1970 and 1999, we examined the cumulative incidence of late (> 5 years from diagnosis) mortality, SMN, and CHCs (grades 2-5 and 3-5). Multivariable Cox regression models [...]
Approches psycho-sociales (1)
A partir d'une revue systématique de la littérature (37 études, 5 902 patientes), cette méta-analyse évalue l'intérêt de thérapies de groupe pour soulager la détresse psychique de patientes atteintes d'un cancer du sein de stade non métastatique
Efficacy of group therapy to reduce mental distress in women with non-metastatic breast cancer: A systematic review and meta-analysis of randomized...
A partir d'une revue systématique de la littérature (37 études, 5 902 patientes), cette méta-analyse évalue l'intérêt de thérapies de groupe pour soulager la détresse psychique de patientes atteintes d'un cancer du sein de stade non métastatique
Efficacy of group therapy to reduce mental distress in women with non-metastatic breast cancer: A systematic review and meta-analysis of randomized controlled trials
Rosendahl, Jenny ; Gawlytta, Romina ; Ressel, Eva ; Rodeck, Johanna ; Strauss, Bernhard ; Mehnert-Theuerkauf, Anja ; Koranyi, Susan
Objective: Group treatments have proven to be effective for many mental disorders and showed beneficial effects in patients with medical illness. Aim of this systematic review and meta-analysis is to summarize the efficacy of group therapy for women with non-metastatic breast cancer. Methods: We included studies comparing group therapy for women with non-metastatic breast cancer to non-active control groups, active control conditions, and individual psychotherapy. The primary outcome was mental [...]
